Eli Lilly has responded to criticism of high prices for insulin products in the US by launching a cut-price version of its Humalog brand. The ‘authorised generic’ uses the same insulin lispro ...

B.C. has gone from one of the worst public formularies to what I consider to be one of the best. So how did we get here?

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 ...

For the quarter ended March 2026, Eli Lilly (LLY) reported revenue of $19.8 billion, up 55.6% over the same period last year. EPS came in at $8.55, compared to $3.34 in the year-ago quarter. The ...

The upcoming report from Eli Lilly (LLY) is expected to reveal quarterly earnings of $7.26 per share, indicating an increase of 117.4% compared to the year-ago period. Analysts forecast revenues of ...

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...

These skilled and patient tattoo artists know how to create the illusion of 3D with the help of shadows and perspective.

Cash position of €17.2m as of December 31, 2025Progresses achieved with our flagship projects in 2025:Chinese partner Tonghua Dongbao completed BioChaperone® Lispro Phase 3 program with positive ...